Candidate drug for spinal muscular atrophy, with roots in CSHL research, passes major hurdle
In an announcement that delighted the families of patients and surprised many pharmaceutical industry analysts, the biotechnology firms Biogen and Ionis Pharmaceuticals on Monday said they had decided to cut short a phase-3 ...
Aug 4, 2016
0
6